Histologic subtype needs to be considered after partial nephrectomy in patients with pathologic T1a renal cell carcinoma: papillary vs. clear cell renal cell carcinoma

Histologic subtype needs to be considered after partial nephrectomy in patients with pathologic... J Cancer Res Clin Oncol (2017) 143:1845–1851 DOI 10.1007/s00432-017-2430-6 ORIGINAL ARTICLE – CLINICAL ONCOLOGY Histologic subtype needs to be considered after partial nephrectomy in patients with pathologic T1a renal cell carcinoma: papillary vs. clear cell renal cell carcinoma 1 2 2 2 2 Sangjun Yoo · Dalsan You · In Gab Jeong · Cheryn Song · Bumsik Hong · 2 2 2 Jun Hyuk Hong · Hanjong Ahn · Choung‑Soo Kim Received: 9 March 2017 / Accepted: 18 April 2017 / Published online: 27 April 2017 © Springer-Verlag Berlin Heidelberg 2017 Abstract Conclusions In patients with pathologic T1a RCC, recur- Purpose We compared the oncological outcomes of pap- rence after PN occurred more commonly in pRCC com- illary renal cell carcinoma (pRCC) with clear cell renal pared with ccRCC. As over half of the recurrence cases cell carcinoma (ccRCC) after partial nephrectomy (PN) in in patients with pRCC occurred ≥5 years post surgery, a patients with pathologic T1a RCC. longer follow-up time is required, even for those with path- Methods After excluding patients with synchronous multi- ologic stage T1a disease. ple renal tumors, familial RCC, and pathologic stage T1b or above, 759 patients with ccRCC and 84 patients with http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Journal of Cancer Research and Clinical Oncology Springer Journals

Histologic subtype needs to be considered after partial nephrectomy in patients with pathologic T1a renal cell carcinoma: papillary vs. clear cell renal cell carcinoma

Loading next page...
 
/lp/springer_journal/histologic-subtype-needs-to-be-considered-after-partial-nephrectomy-in-0TLbkd93ud
Publisher
Springer Berlin Heidelberg
Copyright
Copyright © 2017 by Springer-Verlag Berlin Heidelberg
Subject
Medicine & Public Health; Oncology; Cancer Research; Internal Medicine; Hematology
ISSN
0171-5216
eISSN
1432-1335
D.O.I.
10.1007/s00432-017-2430-6
Publisher site
See Article on Publisher Site

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Unlimited reading

Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.

Stay up to date

Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.

Organize your research

It’s easy to organize your research with our built-in tools.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

Monthly Plan

  • Read unlimited articles
  • Personalized recommendations
  • No expiration
  • Print 20 pages per month
  • 20% off on PDF purchases
  • Organize your research
  • Get updates on your journals and topic searches

$49/month

Start Free Trial

14-day Free Trial

Best Deal — 39% off

Annual Plan

  • All the features of the Professional Plan, but for 39% off!
  • Billed annually
  • No expiration
  • For the normal price of 10 articles elsewhere, you get one full year of unlimited access to articles.

$588

$360/year

billed annually
Start Free Trial

14-day Free Trial